Text size fake pictures Shares of AstraZeneca rose on Thursday as new drug sales helped the British pharmaceutical giant exceed expectations in the second quarter. Late-stage trials for its experimental coronavirus vaccine, developed with the University of Oxford, have also begun in the UK, Brazil and South Africa, the company …
Read More »Johnson & Johnson begins trial of one-dose Covid-19 vaccine
Text size Johnson & Johnson became the third western biopharmaceutical company to start a new test of its Covid-19 vaccine this week, but with one difference: in a surprise announcement Thursday morning, the company said it would test its vaccine in a format single dose. Moderna (MRNA) and Pfizer (PFE) …
Read More »Pfizer shares rise after earnings. Here’s why stocks rose more.
Text size Spencer Platt / Getty Images Large pharmaceutical company Pfizer announced second-quarter financial results on Tuesday morning that exceeded Wall Street expectations, sending shares of around 3% in pre-trade. The company reported earnings of $ 0.78 per share, beating the FactSet consensus at $ 0.10 and the S&P Capital …
Read More »Pfizer CEO says companies should profit from Covid-19 vaccines
Text size Albert Bourla, CEO of the pharmaceutical company Pfizer Drew Angerer / Getty Images Albert Bourla, Pfizer‘s CEO, he has no patience with the argument that pharmaceutical companies should not make a profit from the drugs and vaccines they introduce to fight Covid-19. “I think it is very bad,” …
Read More »Moderna is asking for $ 60 for the Covid-19 vaccine, according to the report
Text size Photograph by JOSEPH PREZIOSO / AFP via Getty Images The Modern biotechnology company, which has received commitments of nearly $ 1 billion from the federal government to develop its Covid-19 vaccine, seeks to sell the vaccine for between $ 25 and $ 30 per dose, the Financial Times …
Read More »